Evidence map›Paper›PMID 38254595›Full record

ArticleFoods (Basel, Switzerland)2024

Exploring the Blood Glucose-Lowering Potential of the Umami Peptides LADW and EEAEGT Derived from Tuna Skeletal Myosin: Perspectives from α-Glucosidase Inhibition and Starch Interaction.

Shuai Zhao, Shengbao Cai, Lixin Ding, Junjie Yi, Linyan Zhou, Zhijia Liu, Chuanqi Chu

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Horticulture research · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Food chemistry: X · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shuai ZhaoFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.
Shengbao CaiFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.ORCID 0000-0002-2492-5062
Lixin DingFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.
Junjie YiFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.
Linyan ZhouFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.ORCID 0000-0001-9798-6264
Zhijia LiuFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.ORCID 0000-0002-7991-2197
Chuanqi ChuFaculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.
Kunming University of Science and Technology · CN

Funding

Addressing Geriatric Syndromes within Permanent Supportive HousingR21AG050009 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENWOOD, BENJAMIN FOSTER · 2016 to 2017
$463k
NIA NIH HHS R21 AG050009
6 · The paper itself

Abstract

This study aimed to explore the potential of umami peptides for lowering blood glucose. Molecular docking results showed that the peptides LADW and EEAEGT bound to the active amino acid residues of α-glucosidase via hydrogen bonds and Van der Waals forces, a finding supported by an independent gradient model (IGM). Molecular dynamics (MD) simulations demonstrated that the peptides LADW and EEAEGT can decelerate the outward expansion of α-glucosidase and reduce amino acid fluctuations at the active site. In vitro findings indicated that the peptides LADW and EEAEGT showed potent inhibitory activity against α-glucosidase, with IC

Indexed as

independent gradient modelmolecular dockingmolecular dynamics simulationstarch hydrolysis inhibitionweak interaction forceα-glucosidase inhibitory peptides

Identifiers

PMID38254595
PMCPMC10815170
OpenAlexW4390947362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.